Login / Signup

Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.

Nisreen M A OkbaIvy WidjajaBrenda van DierenAndrea AebischerGeert van AmerongenLeon de WaalKoert J StittelaarDebby SchipperByron MartinaJudith M A van den BrandMartin BeerBerend-Jan BoschBart L Haagmans
Published in: Emerging microbes & infections (2020)
Middle East respiratory syndrome coronavirus (MERS-CoV) is a WHO priority pathogen for which vaccines are urgently needed. Using an immune-focusing approach, we created self-assembling particles multivalently displaying critical regions of the MERS-CoV spike protein ─fusion peptide, heptad repeat 2, and receptor binding domain (RBD) ─ and tested their immunogenicity and protective capacity in rabbits. Using a "plug-and-display" SpyTag/SpyCatcher system, we coupled RBD to lumazine synthase (LS) particles producing multimeric RBD-presenting particles (RBD-LS). RBD-LS vaccination induced antibody responses of high magnitude and quality (avidity, MERS-CoV neutralizing capacity, and mucosal immunity) with cross-clade neutralization. The antibody responses were associated with blocking viral replication and upper and lower respiratory tract protection against MERS-CoV infection in rabbits. This arrayed multivalent presentation of the viral RBD using the antigen-SpyTag/LS-SpyCatcher is a promising MERS-CoV vaccine candidate and this platform may be applied for the rapid development of vaccines against other emerging viruses such as SARS-CoV-2.
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • respiratory tract
  • immune response
  • binding protein
  • case report
  • high glucose
  • dendritic cells
  • candida albicans
  • quality improvement
  • stress induced